A 51-year-old man with chronic ankle oedema, orthopnoea, and raised NT-proBNP is diagnosed with HFrEF (EF 30%). Which mortality-reducing drug combinat...

Question

A 51-year-old man with chronic ankle oedema, orthopnoea, and raised NT-proBNP is diagnosed with HFrEF (EF 30%). Which mortality-reducing drug combination is foundational therapy?

Accepted Answer

ACE inhibitor + beta blocker + mineralocorticoid receptor antagonist

Answer

Loop diuretic + digoxin

Answer

SGLT2 inhibitor only

Answer

Verapamil + nitrate

Answer

Hydralazine alone

ukmla MCQ (SBA): Heart Failure (HFrEF)

A 51-year-old man with chronic ankle oedema, orthopnoea, and raised NT-proBNP is diagnosed with HFrEF (EF 30%). Which mortality-reducing drug combination is foundational therapy?